Utah Historical Income Statement

UTMD Stock

USD 68.52 0.61 0.90%

Historical analysis of Utah Medical income statement accounts such as Depreciation And Amortization of 6.7 M, Total Revenue of 36.6 M, Gross Profit of 20.5 M or Other Operating Expenses of 23.8 M can show how well Utah Medical Products performed in making a profits. Evaluating Utah Medical income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Utah Medical's future profits or losses.

Cash Flow Balance Sheet Income Statement

Oil Shock

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Utah Medical Products latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Utah Medical Products is a good buy for the upcoming year.

Net Income Gross Profit

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Utah Medical Products. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

About Utah Income Statement Analysis

Utah Medical Products Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Utah Medical shareholders. The income statement also shows Utah investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Utah Medical Income Statement Chart

At present, Utah Medical's Total Operating Expenses is projected to increase significantly based on the last few years of reporting. The current year's Income Tax Expense is expected to grow to about 3.8 M, whereas Total Revenue is forecasted to decline to about 36.6 M.

Total Revenue Gross Profit Other Operating Expenses Operating Income

Total Revenue

Total revenue comprises all receipts Utah Medical Products generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Gross Profit

Gross profit is a required income statement account that reflects total revenue of Utah Medical Products minus its cost of goods sold. It is profit before Utah Medical operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Utah Medical Products. It is also known as Utah Medical overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Operating Income

Operating Income is the amount of profit realized from Utah Medical Products operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Utah Medical Products is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.

Most accounts from Utah Medical's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Utah Medical Products current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Utah Medical Products. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

	2021	2022	2023	2024 (projected)
Gross Profit	30.9M	32.2M	24.3M	20.5M
Total Revenue	49.1M	52.3M	50.2M	36.6M

Gross Profit Total Revenue

Utah Medical income statement Correlations

	Depreciation And Amortization	Interest Expense	Total Revenue	Gross Profit	Other Operating Expenses	Operating Income	Ebit	Ebitda	Cost Of Revenue	Total Operating Expenses	Income Before Tax	Net Income	Income Tax Expense	Total Other Income Expense Net	Research Development	Selling General Administrative	Extraordinary Items	Selling And Marketing Expenses	Net Income From Continuing Ops	Non Operating Income Net Other	Tax Provision	Interest Income	Reconciled Depreciation
Depreciation And Amortization		0.48	0.69	0.62	0.58	0.11	0.21	0.36	0.68	0.65	0.54	0.58	0.06	0.68	-0.47	0.84	0.02	-0.43	0.4	0.06	-0.15	0.83	0.95
Interest Expense	0.48		0.19	0.28	0.11	-0.29	-0.02	0.09	0.02	0.55	0.05	0.1	-0.1	0.55	-0.13	0.45	0.09	-0.17	-0.05	-0.44	-0.15	0.31	0.47
Total Revenue	0.69	0.19		0.96	0.83	0.69	0.3	0.42	0.9	0.72	0.94	0.86	0.37	0.36	-0.87	0.53	-0.54	-0.03	0.25	0.22	0.03	0.43	0.48
Gross Profit	0.62	0.28	0.96		0.74	0.67	0.25	0.36	0.75	0.82	0.92	0.81	0.41	0.37	-0.88	0.42	-0.57	-0.02	0.2	0.16	0.08	0.33	0.39
Other Operating Expenses	0.58	0.11	0.83	0.74		0.38	0.18	0.28	0.84	0.61	0.7	0.67	0.22	0.52	-0.77	0.48	-0.53	0.17	0.18	0.19	-0.09	0.36	0.39
Operating Income	0.11	-0.29	0.69	0.67	0.38		0.27	0.29	0.62	0.2	0.81	0.65	0.49	-0.36	-0.7	-0.07	-0.61	0.09	0.01	0.39	0.23	-0.01	-0.09
Ebit	0.21	-0.02	0.3	0.25	0.18	0.27		0.98	0.32	0.22	0.19	-0.07	0.57	-0.14	-0.24	0.18	-0.56	0.1	-0.33	-0.59	0.5	-0.27	0.12
Ebitda	0.36	0.09	0.42	0.36	0.28	0.29	0.98		0.43	0.33	0.3	0.05	0.55	0.0	-0.31	0.34	-0.53	0.04	-0.25	-0.57	0.46	-0.14	0.26
Cost Of Revenue	0.68	0.02	0.9	0.75	0.84	0.62	0.32	0.43		0.47	0.82	0.8	0.24	0.29	-0.71	0.63	-0.41	-0.04	0.29	0.28	-0.04	0.51	0.55
Total Operating Expenses	0.65	0.55	0.72	0.82	0.61	0.2	0.22	0.33	0.47		0.52	0.48	0.19	0.53	-0.67	0.49	-0.44	0.14	0.3	-0.2	-0.1	0.31	0.45
Income Before Tax	0.54	0.05	0.94	0.92	0.7	0.81	0.19	0.3	0.82	0.52		0.89	0.44	0.25	-0.82	0.35	-0.47	-0.2	0.15	0.4	0.14	0.37	0.36
Net Income	0.58	0.1	0.86	0.81	0.67	0.65	-0.07	0.05	0.8	0.48	0.89		-0.01	0.34	-0.69	0.44	-0.22	-0.19	0.41	0.57	-0.3	0.57	0.44
Income Tax Expense	0.06	-0.1	0.37	0.41	0.22	0.49	0.57	0.55	0.24	0.19	0.44	-0.01		-0.11	-0.46	-0.1	-0.6	-0.06	-0.49	-0.22	0.9	-0.3	-0.07
Total Other Income Expense Net	0.68	0.55	0.36	0.37	0.52	-0.36	-0.14	0.0	0.29	0.53	0.25	0.34	-0.11		-0.16	0.68	0.24	-0.39	0.23	-0.03	-0.17	0.58	0.71
Research Development	-0.47	-0.13	-0.87	-0.88	-0.77	-0.7	-0.24	-0.31	-0.71	-0.67	-0.82	-0.69	-0.46	-0.16		-0.14	0.76	-0.13	0.01	-0.26	-0.07	-0.21	-0.19
Selling General Administrative	0.84	0.45	0.53	0.42	0.48	-0.07	0.18	0.34	0.63	0.49	0.35	0.44	-0.1	0.68	-0.14		0.22	-0.33	0.47	-0.12	-0.16	0.73	0.9
Extraordinary Items	0.02	0.09	-0.54	-0.57	-0.53	-0.61	-0.56	-0.53	-0.41	-0.44	-0.47	-0.22	-0.6	0.24	0.76	0.22		-0.56	0.31	0.18	-0.32	0.42	0.3
Selling And Marketing Expenses	-0.43	-0.17	-0.03	-0.02	0.17	0.09	0.1	0.04	-0.04	0.14	-0.2	-0.19	-0.06	-0.39	-0.13	-0.33	-0.56		0.03	-0.27	-0.15	-0.54	-0.58
Net Income From Continuing Ops	0.4	-0.05	0.25	0.2	0.18	0.01	-0.33	-0.25	0.29	0.3	0.15	0.41	-0.49	0.23	0.01	0.47	0.31	0.03		0.31	-0.55	0.57	0.42
Non Operating Income Net Other	0.06	-0.44	0.22	0.16	0.19	0.39	-0.59	-0.57	0.28	-0.2	0.4	0.57	-0.22	-0.03	-0.26	-0.12	0.18	-0.27	0.31		-0.33	0.44	0.03
Tax Provision	-0.15	-0.15	0.03	0.08	-0.09	0.23	0.5	0.46	-0.04	-0.1	0.14	-0.3	0.9	-0.17	-0.07	-0.16	-0.32	-0.15	-0.55	-0.33		-0.42	-0.15
Interest Income	0.83	0.31	0.43	0.33	0.36	-0.01	-0.27	-0.14	0.51	0.31	0.37	0.57	-0.3	0.58	-0.21	0.73	0.42	-0.54	0.57	0.44	-0.42		0.88
Reconciled Depreciation	0.95	0.47	0.48	0.39	0.39	-0.09	0.12	0.26	0.55	0.45	0.36	0.44	-0.07	0.71	-0.19	0.9	0.3	-0.58	0.42	0.03	-0.15	0.88

Click cells to compare fundamentals

Utah Medical Account Relationship Matchups

Utah Medical income statement Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Depreciation And Amortization	6.9M	7.2M	7.3M	7.1M	6.4M	6.7M
Interest Expense	7.1M	7.3M	4.2M	(869K)	(999.4K)	(949.4K)
Total Revenue	46.9M	42.2M	49.1M	52.3M	50.2M	36.6M
Gross Profit	29.5M	25.5M	30.9M	32.2M	24.3M	20.5M
Other Operating Expenses	29.3M	28.5M	18.1M	32.5M	31.8M	23.8M
Operating Income	10.8M	6.5M	18.9M	12.7M	18.4M	11.8M
Ebit	10.8M	6.5M	23.6M	12.7M	18.4M	11.6M
Ebitda	17.6M	13.7M	30.9M	19.8M	24.8M	14.1M
Cost Of Revenue	17.4M	16.6M	18.1M	20.1M	25.9M	16.1M
Total Operating Expenses	11.8M	11.8M	12.0M	12.4M	5.9M	8.1M
Income Before Tax	17.9M	13.8M	19.1M	20.7M	20.1M	13.0M
Net Income	14.7M	10.8M	14.8M	16.5M	16.6M	9.6M
Income Tax Expense	3.2M	3.0M	4.3M	4.2M	3.5M	3.8M
Total Other Income Expense Net	7.1M	7.3M	181K	8.0M	1.7M	1.3M
Research Development	483K	486K	526K	493K	560K	472.8K
Selling General Administrative	9.6M	9.8M	10.1M	10.4M	11.0M	6.9M
Net Income Applicable To Common Shares	14.7M	10.8M	14.8M	16.5M	18.9M	11.8M
Selling And Marketing Expenses	1.7M	1.6M	1.4M	1.5M	1.7M	1.5M
Net Income From Continuing Ops	14.7M	13.8M	19.1M	20.7M	16.9M	16.8M
Non Operating Income Net Other	(2K)	20K	15K	208K	239.2K	251.2K
Tax Provision	3.2M	3.0M	4.3M	4.2M	3.8M	3.4M
Reconciled Depreciation	6.9M	7.2M	7.3M	7.1M	7.1M	6.5M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

CRM	Salesforce
CRM	Salesforce
S	SentinelOne

When determining whether Utah Medical Products is a strong investment it is important to analyze Utah Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Utah Medical's future performance. For an informed investment choice regarding Utah Stock, refer to the following important reports:

How To Invest In Utah

Details

Is Utah Stock a good investment?

Details

What is Utah Medical's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.

Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Utah Medical. If investors know Utah will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Utah Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.05)

Dividend Share

1.2

Earnings Share

4.28

Revenue Per Share

12.392

Quarterly Revenue Growth

(0.20)

The market value of Utah Medical Products is measured differently than its book value, which is the value of Utah that is recorded on the company's balance sheet. Investors also form their own opinion of Utah Medical's value that differs from its market value or its book value, called intrinsic value, which is Utah Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Utah Medical's market value can be influenced by many factors that don't directly affect Utah Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Utah Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Utah Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Utah Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Utah Historical Income Statement

About Utah Income Statement Analysis

Utah Medical Income Statement Chart

Total Revenue

Gross Profit

Other Operating Expenses

Operating Income

Utah Medical income statement Correlations

Utah Medical Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Utah Medical income statement Accounts

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Ebitda	+ 0.98	Ebit
Gross Profit	+ 0.96	Total Revenue
Reconciled Depreciation	+ 0.95	Depreciation And Amortization
Income Before Tax	+ 0.94	Total Revenue
Income Before Tax	+ 0.92	Gross Profit
Cost Of Revenue	+ 0.9	Total Revenue

Research Development	- 0.88	Gross Profit
Research Development	- 0.87	Total Revenue
Research Development	- 0.82	Income Before Tax
Research Development	- 0.77	Other Operating Expenses
Research Development	- 0.71	Cost Of Revenue
Research Development	- 0.7	Operating Income